Transgene
Biotechnology ResearchBas-Rhin, France201-500 Employees
Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer.
Insights
Executive Appointments Transgene has recently appointed key executives including a Chief Financial Officer, Chief Human Resources Officer, and Chief Business Officer. These appointments indicate potential opportunities for solution providers offering services tailored to support new leadership in achieving company objectives.
Collaboration & Funding Transgene's collaboration with NEC to develop a head and neck cancer vaccine and the receipt of funding for its myvac(R) platform demonstrates the company's commitment to innovation. Sales professionals can explore partnership opportunities with Transgene to provide complementary technologies or services.
Employee Promotions The promotion of key personnel to roles such as Vice President of Corporate Communications and Investor Relations presents prospects for firms specializing in internal communications, investor relations support, or corporate branding services to engage with Transgene and enhance its outreach capabilities.
Market Recognition Transgene's receipt of the "Investment for the Future" award showcases external validation of its research and development efforts. Sales teams can leverage this recognition to position their offerings as valuable assets that align with Transgene's strategic vision and industry recognition.
Revenue Growth With a revenue range of $50M - $100M and funding of $16M, Transgene demonstrates financial stability and potential for growth. Sales representatives can target the company with solutions that streamline operations, enhance productivity, or drive further revenue generation in line with its financial health.
Similar companies to Transgene
Amgen
36K
$1B4D Molecular Therapeutics
222$10M$50MMerck
41K$1BOSE Immunotherapeutics
69$10M$50MTurnstone Biologics
91$10M$50M
Transgene Tech Stack
Transgene uses 8 technology products and services including Site Kit, WordPress, CookieYes, and more. Explore Transgene's tech stack below.
- Site KitAnalytics
- WordPressContent Management System
- CookieYesCookie Compliance
- jQueryJavascript Libraries
- prettyPhotoJavascript Libraries
- Contact Form 7Web Platform Extensions
- GoDaddy CoBlocksWeb Platform Extensions
- TwitterWidgets
Media & News
Transgene's Email Address Formats
Transgene uses at least 1 format(s):
| Transgene Email Formats | Percentage |
| Last@transgene.fr | 64% |
| FirstLast@transgene.fr | 25% |
| First.Last@transgene.fr | 9% |
| F.Last@transgene.fr | 2% |
Frequently Asked Questions
Where is Transgene's headquarters located?
Transgene's main headquarters is located at Illkirch-Graffenstaden, Bas-Rhin 67400 FR. The company has employees across 4 continents, including EuropeAsiaNorth America. What is Transgene's phone number?
You can contact Transgene's main corporate office by phone at +33-3-88-27-9****
What is Transgene's official website and social media links?
Transgene's official website is transgene.fr and has social profiles on LinkedIn.How much revenue does Transgene generate?
As of September 2024, Transgene's annual revenue reached $75M. What is Transgene's SIC code NAICS code?
Transgene's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Transgene have currently?
As of September 2024, Transgene has approximately 209 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Chief Business Officer: J. W.Head Of Process Sciences: S. R.Head Of Vectorology Laboratory: N. S.. Explore Transgene's employee directory with LeadIQ.What industry does Transgene belong to?
Transgene operates in the Biotechnology Research industry. What technology does Transgene use?
Transgene's tech stack includes Site KitWordPressCookieYesjQueryprettyPhotoContact Form 7GoDaddy CoBlocksTwitter. What is Transgene's email format?
Transgene's email format typically follows the pattern of . Find more Transgene email formats with LeadIQ. How much funding has Transgene raised to date?
As of September 2024, Transgene has raised $16M in funding. The last funding round occurred on Jul 17, 2023 for $16M.When was Transgene founded?
Transgene was founded in 1979.
Company Overview
- Headquarters
- Illkirch-Graffenstaden, Bas-Rhin 67400 FR
- Phone number
- +33-3-88-27-9****
- Website
- transgene.fr
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 1979
- Employees
- 201-500
Media & News
Funding & Financials
- $16M
Transgene has raised a total of $16M of funding over 4 rounds. Their latest funding round was raised on Jul 17, 2023 in the amount of $16M.
- $50M$100M
Transgene's revenue is in the range of $50M$100M
Funding & Financials
- $16M
Transgene has raised a total of $16M of funding over 4 rounds. Their latest funding round was raised on Jul 17, 2023 in the amount of $16M.
- $50M$100M
Transgene's revenue is in the range of $50M$100M
Company Leadership
J. W.Chief Business Officer
S. R.Head Of Process Sciences- N. S.Head Of Vectorology Laboratory
- B. B.Head Of Biometry (biostatistics, Data Management)
- C. S.Head Of Toxicology
Employee Directory
- B. B.Head Of Biometry (biostatistics, Data Management)
- C. S.Head Of Toxicology
- E. B.Head Of Analytical (qc) Developement Department
- H. K.Head Of Department
- K. L.Head Of Program Management
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
